SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (674)9/3/1999 7:39:00 AM
From: Dr. John M. de Castro  Read Replies (1) of 4474
 
DAK, my understanding is that there a 5,000 toxics out there and that they have not yet been converted. There were some stipulations regarding the second tranch which I believe ARIA has not yet been able to meet. It's kinda scarry to think that this company isn't even able to meet the stipulations of a floorless convertible. I'd appreciate corrections if my interpretation is incorrect.

In regard to dillution, until these toxics are converted we will not see there dillutive effects. At current levels the toxics could convert into about 7MM shares. If the stock goes lower, say to 1/2, then that number goes up to nearly 12MM shares.

Best regards
John de C
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext